Skip to content
Catalyst
Sign in

PapersPMID:22930403

Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial.

Molecular nutrition & food research2013The record ↗

01 · findings
3
02 · compound
1
03 · endpoints
3
04 · null
0
PMID:22930403 · 3 findings, in bands by direction at evidence strength
  1. Finding, very limited evidencelowersFasting blood glucose
  2. Finding, very limited evidencelowersHOMA-IR
  3. Finding, very limited evidencelowersGlycated haemoglobin (HbA1c)
Dose studied, every finding
300 mg/day
Population, every finding
overweight/obese adults with type 2 diabetes (BMI ≥ 24; fasting glucose ≥ 7.0 mmol/L or postprandial glucose ≥ 11.1 mmol/L)

What moved

3 findingsHow to read these marks →

  • curcumin — decreases fasting blood glucose

    very limitedFindingreplicated ×5

    “Curcuminoids supplementation significantly decreased fasting blood glucose (p < 0.01), HbA1c (p = 0.031), and insulin resistance index (HOMA-IR) (p < 0.01) in type 2 diabetic patients.”
    Quoted verbatim from Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial.
    Study
    RCT
    Participants
    100
    Duration
    3 months

    Permalink

  • curcumin — decreases HOMA-IR

    very limitedFindingreplicated ×3

    “Curcuminoids supplementation significantly decreased fasting blood glucose (p < 0.01), HbA1c (p = 0.031), and insulin resistance index (HOMA-IR) (p < 0.01) in type 2 diabetic patients.”
    Quoted verbatim from Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial.
    Study
    RCT
    Participants
    100
    Duration
    3 months

    Permalink

  • curcumin — decreases glycated haemoglobin (HbA1c)

    very limitedFindingreplicated ×4

    “Curcuminoids supplementation significantly decreased fasting blood glucose (p < 0.01), HbA1c (p = 0.031), and insulin resistance index (HOMA-IR) (p < 0.01) in type 2 diabetic patients.”
    Quoted verbatim from Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial.
    Study
    RCT
    Participants
    100
    Duration
    3 months

    Permalink

Study record

Read under
curcumin
Design
randomised controlled trial
Species
human
Population
overweight/obese adults with type 2 diabetes (BMI ≥ 24; fasting glucose ≥ 7.0 mmol/L or postprandial glucose ≥ 11.1 mmol/L)
Participants
100
Comparator
placebo
Duration
90 days
Endpoints measured
6
Record
extracted
Readings recorded
2